Abraxane and Temodar Plus Genasense in Advanced Melanoma
Clinical trial NCT00409383 · UNKNOWN
Trial details
- NCT number
- NCT00409383
- Sponsor
- Genta Incorporated
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2013-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.